The surface of the chip is layered with a combination of gold and silica, enhancing the chip’s electric and magnetic fields and forming a “metasurface,” according to an Oct. 16 report from New Atlas.
When patient blood interacts with the pattern of gold and silica on the chip’s metasurface, chemical analysis through spectroscopy is quickly able to identify heart attack biomarkers, even at low concentrations, within minutes.
Read the full study here.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
